A 44-year-old woman had a transient ischemic stroke, fibroelastoma of the mitral valve being the source of the embolus. The patient evolved with neutropenia induced by ticlopidine after 10 days of treatment. We report the major clinical features, therapeutical options, and medicamentous toxicity resulting from the use of antiplatelet drugs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/s0066-782x2001000700009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cardiac papillary fibroelastoma involving the mitral valve: A case report.
Medicine (Baltimore)
January 2025
Ultrasound Medical Center, Second Hospital of Lanzhou University, Lanzhou, China.
Rationale: Cardiac papillary fibroelastoma (CPF) is a rare cardiac tumor that can lead to severe and potentially fatal complications such as stroke, myocardial infarction, and sudden cardiac death. The rarity of CPF makes it challenging for clinicians to diagnose and treat, highlighting the importance of timely and accurate diagnosis to prevent catastrophic outcomes. This case report aims to contribute to the clinical understanding of CPF involving the mitral valve (MV), providing insights into diagnosis and treatment strategies.
View Article and Find Full Text PDFCardiac Papillary Fibroelastoma and Cerebrovascular Events: A Systematic Review.
CJC Open
November 2024
Department of Cardiology, Memorial Healthcare System, Florida, USA.
Background: Cardiac papillary fibroelastomas (CPFs) are benign endocardial tumours with embolic potential. This article is a systematic review to identify the clinical profile, diagnosis, tumour characteristics, and treatment modalities in patients with CPF presenting with stroke or transient ischemic attack (TIA).
Methods: This systematic review was conducted using the PubMed and Embase databases, including case reports and/or series and observational studies (for a search period of up until April 2022).
[A rare case of papillary fibroelastoma revealed by ischemic stroke (case report)].
Ann Cardiol Angeiol (Paris)
December 2024
Département de Cardiologie, Hôpital Universitaire International CHEIKH KHALIFA, Casablanca, Maroc.
Article Synopsis
- Papillary fibroelastoma is a rare but potentially dangerous benign heart tumor that can lead to serious complications like ischemic strokes and sudden death if not surgically removed urgently.
- A case study of a 34-year-old man who experienced an ischemic stroke revealed a mobile tumor located near the mitral valve, which was successfully excised via surgery with no complications.
- The surgery confirmed the diagnosis of papillary fibroelastoma and the patient's condition improved, highlighting the importance of surgical intervention to prevent future embolic events.
Tricuspid Papillary Fibroelastoma: A Rare Tumor in an Uncommon Location.
Cureus
June 2024
Cardiology, Cleveland Clinic Akron General, Akron, USA.
Papillary fibroelastomas (PFEs) are rare benign cardiac tumors typically arising from the valvular endocardium, often affecting the aortic and mitral valves. They can range from asymptomatic to causing severe thromboembolic complications like stroke. This article presents a case of a tricuspid valve PFE in an 81-year-old patient with severe multi-vessel coronary artery disease.
View Article and Find Full Text PDFRobotic-Assisted Resection of Rare Mitral Valve Hemangioma.
Mayo Clin Proc Innov Qual Outcomes
June 2024
Department of Cardiothoracic Surgery, Mayo Clinic, Rochester, MN.
Cardiac hemangiomas are extremely rare tumors accounting for only 1.5%-2.5% of all cardiac tumors.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!